A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism

Journal of Endocrinological Investigation

Volumn 32, Issue 1, 2009, Pages 37-40

  Unluhizarci, Kursad ^a   Ozel, D ^a   Tanriverdi, F ^a   Karaca, Z ^a   Kelestimur, F ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Finasteride; Flutamide; Hirsutism

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FINASTERIDE; FLUTAMIDE; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 64549127776     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345676     Document Type: Article

References (27)

1. Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003, 101: 995-1007.
2. Unluhizarci K, Sahin Y, Kelestimur F. The evaluation and treatment of hirsute women. Women's Health 2005, 1: 429-35.
3. Azziz R, Dewailly D, Owerbach D. Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 1994, 78: 810-5.
4. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000, 21: 347-62.
5. Unluhizarci K, Gokce C, Atmaca H, Bayram F, Kelestimur F. A detailed investigation of hirsutism in a Turkish population: Idiopathic hyperandrogenemia as a perplexing issue. Exp Clin Endocrinol Diabetes 2004, 112: 504-9.
6. Ibáñez L, Jaramillo A, Ferrer A, de Zegher F. Absence of hepatotoxicity after long term, low-dose flutamide in hyperandrogenic girls and young women. Hum Reprod 2005, 20: 1833-6.
7. Fruzzetti F, Bersi C, Parrini D, Ricci C, Genazzani AR. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects. Fertil Steril 1999, 71: 445-51.
8. Moghetti P, Tosi F, Tosti A, et al. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2000, 85: 89-94.
9. Lumachi F, Rondinone R. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism. Fertil Steril 2003, 79: 942-6.
10. Sahin Y, Kelestimur F. Medical treatment regimens of hirsutism. Reprod BioMed Online 2004, 8: 538-46.
11. Kelestimur F, Everest H, Unluhizarci K, Bayram F, Sahin Y. A comparison between spironolactone plus finasteride and spironolactone in the treatment of hirsutism. Eur J Endocrinol 2004, 150: 351-4.
12. Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999, 72: 915-25.
13. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obtet Gynecol 1981, 140: 815-30.
14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81: 19-25.
15. Pazos F, Escobar-Morreale HF, Balsa J, Sancho JM, Varela C. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contaceptive, in the treatment of hirsutism. Fertil Steril 1999, 71: 122-8.
16. Kelestimur F, Sahin Y. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism. Fertil Steril 1998, 69: 66-9.
17. Sahin Y, Dilber S, Kelestimur F. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril 2001, 75: 496-500.
18. Bayram F, Müderris II, Sahin Y, Kelestimur F. Finasteride treatment for one year in 35 hirsute patients. Exp Clin Endocrinol Diabetes 1999, 107: 195-7.
19. Bayram F, Müderris I, Güven M, Ozçelik B, Keleştimur F. Low dose (2.5 mg/day) finasteride treatment in hirsutism. Gynecol Endocrinol 2003, 17: 419-22.
20. Erenus M, Gürbüz 0, Durmuşoǧlu F, Demirçay Z, Pekin S. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil Steril 1994, 61: 613-6.
21. Falsetti L, Gambera A. Comparison of finaseride versus flutamide in the treatment of hirsutism. Eur J Endocrinol 1999, 141: 361-7.
22. Ibáñez L, Potau N, Marcos MV, de Zegher F. Treatment of hirsutism, hyperandragenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in non-obese, adolescent girls: effect of flutamide. J Clin Endocrinol Metab 2000, 85: 3251-5.
23. Müderris II, Bayram F, Sahin Y, Kele timur F. A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism. Fertil Steril 1997, 68: 644-7.
24. Müderris II, Bayram F. Clinical efficacy of lower dose flutamide 125 mg/d in the treatment of hirsutism. J Endocrinol Invest 1999, 22: 165-8.
25. Müderris II, Bayram F, Güven M. Treatment of hirsutism with lowest-dose flutamide (62.5 mglday). Gynecol Endocrinol 2000, 14: 38-41.
26. Carmina E, Lobo RA. Peripheral andorgen blockade versus glandular androgen suppression in the treatment of hirsutism. Obstet Gynecol 1991, 78: 845-9.
27. Simard J, Luthy I, Guay J, Bélanger A, Labrie F. Characteristics of interaction of the anti-androgen flutamide with androgen receptor in various target tissues. Mol Cell Endocrinol 1986, 44: 261-70.